Free Trial

Alto Neuroscience (ANRO) SEC Filings & 10K Form

Alto Neuroscience logo
$4.16 -0.11 (-2.58%)
(As of 02:58 PM ET)

Recent Alto Neuroscience SEC Filings

DateFilerForm TypeView
11/14/2024
4:46 PM
Alto Neuroscience (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
6:00 AM
Alto Neuroscience (Subject)
Etkin Amit (Filed by)
Form SC 13G
10/22/2024
3:35 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
3:11 PM
Alto Neuroscience (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/13/2024
3:33 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:36 PM
Alto Neuroscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2024
3:19 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
4:19 PM
Alto Neuroscience (Issuer)
Hanley Jr. Michael Conick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:29 AM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
3:15 PM
Alto Neuroscience (Issuer)
Smith Nicholas Conrad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
11:54 AM
Alto Neuroscience (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
03/21/2024
3:19 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
3:49 PM
Alto Neuroscience (Issuer)
Radhakrishnan Maha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
3:47 PM
Alto Neuroscience (Issuer)
Radhakrishnan Maha (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/11/2024
7:20 AM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
8:15 AM
Alto Neuroscience (Issuer)
Angermayer Christian (Reporting)
Apeiron Investment Group Ltd. (Reporting)
Apeiron Presight Capital Fund II, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
Alto Neuroscience (Issuer)
Etkin Amit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
Alto Neuroscience (Issuer)
Smith Nicholas Conrad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:00 PM
Alto Neuroscience (Issuer)
Savitz Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
8:31 AM
Alpha Wave Global, LP (Filed by)
Alto Neuroscience (Subject)
Form SC 13G
02/07/2024
3:25 PM
Alto Neuroscience (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
02/06/2024
3:56 PM
Alto Neuroscience (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/05/2024
3:40 PM
Alto Neuroscience (Issuer)
Dreyfus Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:42 PM
Alto Neuroscience (Issuer)
Cox Christopher Nixon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:43 PM
Alto Neuroscience (Issuer)
Chen Po Yu (0002008609) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:45 PM
Alto Neuroscience (Issuer)
Manji Husseini (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:47 PM
Alto Neuroscience (Issuer)
York Gwill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:02 AM
Alto Neuroscience (Filer)
Form 424B4
02/02/2024
3:54 PM
Alto Neuroscience (Issuer)
Angermayer Christian (Reporting)
Apeiron Investment Group Ltd. (Reporting)
Apeiron Presight Capital Fund II, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
11:15 PM
Alto Neuroscience (Filer)
Form EFFECT
02/01/2024
5:53 PM
Alpha Wave Global, LP (Reporting)
Alpha Wave Ventures GP, Ltd (Reporting)
Alto Neuroscience (Issuer)
Chimera Investment LLC (Reporting)
Lunate Holding RSC Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:53 PM
Alto Neuroscience (Issuer)
Dreyfus Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:55 PM
Alto Neuroscience (Issuer)
Manji Husseini (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:43 PM
Alto Neuroscience (Issuer)
Chen Po Yu (0002008609) (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:45 PM
Alto Neuroscience (Issuer)
Savitz Adam (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:47 PM
Alto Neuroscience (Issuer)
Cox Christopher Nixon (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:47 PM
ALKEON CAPITAL MANAGEMENT LLC (Reporting)
Alto Neuroscience (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:48 PM
Alto Neuroscience (Issuer)
Smith Nicholas Conrad (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:50 PM
Alto Neuroscience (Issuer)
York Gwill (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:52 PM
Alto Neuroscience (Issuer)
Etkin Amit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/01/2024
5:26 PM
Alto Neuroscience (Filer)
Form S-1MEF
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

01/30/2024
3:02 PM
Alto Neuroscience (Filer)
Form 8-A12B
01/29/2024
9:35 AM
Alto Neuroscience (Filer)
Form S-1/A
01/29/2024
6:36 AM
Alto Neuroscience (Filer)
Form S-1/A
01/12/2024
3:50 PM
Alto Neuroscience (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ANRO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners